Cardiovascular risk and metabolic syndrome in primary hyperparathyroidism and their correlation to different clinical forms
- 28 November 2013
- journal article
- research article
- Published by Springer Nature in Endocrine
- Vol. 47 (2) , 581-589
Abstract
Cardiometabolic disorders have been associated with primary hyperparathyroidism (PHPT), while the relationship of cardiovascular risk score (CRS) and metabolic syndrome (MS) with different clinical presentation of PHPT remains undefined. Our aim was to evaluate CRS, MS and its components in PHPT looking for their correlation to different clinical forms. In 68 consecutive PHPT patients and 68 matched controls, CRS, MS and its components were assessed to perform an observational case–control study at an ambulatory referral center for Bone Metabolism Diseases. Patients were stratified in symptomatic and asymptomatic PHPT; these latter were divided in high-risk and low-risk subgroups for end-organ damage. An increased proportion of PHPT patients had intermediate-high CRS and MS (mean, 95 % Confidence Interval (CI) 51.5 %, 39.6–63.3 and 20.6 %, 11.0–30.2, respectively, p < 0.02 vs. controls). Intermediate-high CRS was prevalent both in symptomatic and low-risk asymptomatic PHPT while MS resulted prevalent in low-risk asymptomatic but not in symptomatic PHPT. Type 2 DM, IFG, mixed dyslipidemia, hypertriglyceridemia, HDL-hypocholesterolemia, and LDL-hypercholesterolemia predominated in low-risk asymptomatic, while only LDL-hypercholesterolemia prevailed also in symptomatic PHPT. In patients and controls without cardiometabolic risk factors, HOMA-IR index was significantly increased in PHPT vs. controls (p < 0.03) and associated to total calcium (R = 0.73; p < 0.001). By multivariate analysis low-risk asymptomatic PHPT predicted MS after adjusting for age, sex, and BMI. Our data show an increased frequency of intermediate-high CRS both in symptomatic and low-risk asymptomatic PHPT while MS prevails in low-risk asymptomatic PHPT, supporting the potential for cardiovascular morbidity and mortality also in this form.Keywords
This publication has 37 references indexed in Scilit:
- Coronary Microvascular Dysfunction Induced by Primary Hyperparathyroidism is Restored After ParathyroidectomyCirculation, 2012
- Arterial Hypertension, Metabolic Syndrome and Subclinical Cardiovascular Organ Damage in Patients with Asymptomatic Primary Hyperparathyroidism before and after Parathyroidectomy: Preliminary ResultsInternational Journal of Endocrinology, 2012
- Increased mortality and morbidity in mild primary hyperparathyroid patients. The Parathyroid Epidemiology and Audit Research Study (PEARS)Clinical Endocrinology, 2010
- Insulin resistance is not coupled with defective insulin secretion in primary hyperparathyroidismDiabetic Medicine, 2009
- Plasma Parathyroid Hormone and the Risk of Cardiovascular Mortality in the CommunityCirculation, 2009
- Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Third International WorkshopThe Journal of Clinical Endocrinology & Metabolism, 2009
- 2007 ESH‐ESC Guidelines for the management of arterial hypertensionBlood Pressure, 2007
- Metabolic abnormalities in patients with normocalcemic hyperparathyroidism detected at a population-based screeningEuropean Journal of Endocrinology, 2006
- Prevalence of glucose intolerance in primary hyperparathyroidism and the benefit of parathyroidectomyDiabetes/Metabolism Research and Reviews, 2006
- Impaired glucose tolerance and insulin insensitivity in primary hyperparathyroidismClinical Endocrinology, 1994